↓ Skip to main content

Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea

Overview of attention for article published in BMC Infectious Diseases, February 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
101 Mendeley
Title
Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea
Published in
BMC Infectious Diseases, February 2020
DOI 10.1186/s12879-020-4810-9
Pubmed ID
Authors

Eun Lee, Chul-Hong Kim, Yong Ju Lee, Hyo-Bin Kim, Bong-Seong Kim, Hyung Young Kim, Yunsun Kim, Sangyoung Kim, Chorong Park, Ju-Hee Seo, In Suk Sol, Myongsoon Sung, Min Seob Song, Dae Jin Song, Young Min Ahn, Hea Lin Oh, Jinho Yu, Sungsu Jung, Kyung Suk Lee, Ju Suk Lee, Gwang Cheon Jang, Yoon-Young Jang, Eun Hee Chung, Hai Lee Chung, Sung-Min Choi, Yun Jung Choi, Man Yong Han, Jung Yeon Shim, Jin Tack Kim, Chang-Keun Kim, Hyeon-Jong Yang

Abstract

Community-acquired pneumonia (CAP) is one of the leading worldwide causes of childhood morbidity and mortality. Its disease burden varies by age and etiology and is time dependent. We aimed to investigate the annual and seasonal patterns in etiologies of pediatric CAP requiring hospitalization. We conducted a retrospective study in 30,994 children (aged 0-18 years) with CAP between 2010 and 2015 at 23 nationwide hospitals in South Korea. Mycoplasma pneumoniae (MP) pneumonia was clinically classified as macrolide-sensitive MP, macrolide-less effective MP (MLEP), and macrolide-refractory MP (MRMP) based on fever duration after initiation of macrolide treatment, regardless of the results of in vitro macrolide sensitivity tests. MP and respiratory syncytial virus (RSV) were the two most commonly identified pathogens of CAP. With the two epidemics of MP pneumonia (2011 and 2015), the rates of clinical MLEP and MRMP pneumonia showed increasing trends of 36.4% of the total MP pneumonia. In children < 2 years of age, RSV (34.0%) was the most common cause of CAP, followed by MP (9.4%); however, MP was the most common cause of CAP in children aged 2-18 years of age (45.3%). Systemic corticosteroid was most commonly administered for MP pneumonia. The rate of hospitalization in intensive care units was the highest for RSV pneumonia, and ventilator care was most commonly needed in cases of adenovirus pneumonia. The present study provides fundamental data to establish public health policies to decrease the disease burden due to CAP and improve pediatric health.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 101 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 101 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 14%
Student > Bachelor 12 12%
Student > Master 7 7%
Student > Ph. D. Student 6 6%
Professor 5 5%
Other 23 23%
Unknown 34 34%
Readers by discipline Count As %
Medicine and Dentistry 34 34%
Nursing and Health Professions 7 7%
Agricultural and Biological Sciences 6 6%
Computer Science 3 3%
Biochemistry, Genetics and Molecular Biology 2 2%
Other 12 12%
Unknown 37 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 February 2020.
All research outputs
#14,942,154
of 23,192,960 outputs
Outputs from BMC Infectious Diseases
#4,127
of 7,778 outputs
Outputs of similar age
#255,939
of 456,484 outputs
Outputs of similar age from BMC Infectious Diseases
#77
of 170 outputs
Altmetric has tracked 23,192,960 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,778 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.3. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 456,484 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 170 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.